Farnum Rhonda — SEC Form 4 filings

SEC reporting owner CIK 1898490. 24 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2024-02-22 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Theravance Biopharma, Inc. (TBPH)SVP, COMM & MEDICAL AFFAIRS2421 legs · 140,016 sh · $1,993,89015

Form 4 filings — Farnum Rhonda

FiledFormIssuerReported transactionsSource
2026-09-174Theravance Biopharma, Inc. (TBPH)Sale (S): 3,329 @ $17.03 · Sale (S): 3,328 @ $17.03 · Sale (S): 6,657 @ $17.03EDGAR
2026-08-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 5,667 @ $16.95EDGAR
2026-06-174Theravance Biopharma, Inc. (TBPH)Sale (S): 3,329 @ $16.39 · Sale (S): 3,328 @ $16.38 · Sale (S): 6,657 @ $16.39EDGAR
2026-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 5,678 @ $16.55EDGAR
2026-04-034Theravance Biopharma, Inc. (TBPH)Grant/award (A): 18,750 @ $0EDGAR
2026-03-184Theravance Biopharma, Inc. (TBPH)Sale (S): 7,767 @ $13.92 · Sale (S): 15,534 @ $14 · Sale (S): 7,766 @ $13.92EDGAR
2026-02-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 13,929 @ $19.66EDGAR
2025-12-054Theravance Biopharma, Inc. (TBPH)Sale (S): 7,767 @ $18.75 · Sale (S): 7,766 @ $18.75 · Sale (S): 15,534 @ $18.75EDGAR
2025-11-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,060 @ $17.90EDGAR
2025-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,096 @ $13.39EDGAR
2025-07-164Theravance Biopharma, Inc. (TBPH)Sale (S): 682 @ $11.39 · Sale (S): 5,318 @ $11.39 · Sale (S): 4,000 @ $11.39EDGAR
2025-06-044Theravance Biopharma, Inc. (TBPH)Sale (S): 24,000 @ $11EDGAR
2025-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,120 @ $9.45EDGAR
2025-04-234Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2025-03-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 75,000 @ $0EDGAR
2025-02-244Theravance Biopharma, Inc. (TBPH)Grant/award (A): 5,283 @ $0 · Tax withholding (F): 15,810 @ $9.66EDGAR
2025-01-234Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2024-11-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,178 @ $9.97EDGAR
2024-11-134Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2024-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,222 @ $8.22EDGAR
2024-07-124Theravance Biopharma, Inc. (TBPH)Sale (S): 4,000 @ $9EDGAR
2024-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,268 @ $9.10EDGAR
2024-04-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 37,500 @ $0EDGAR
2024-02-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 18,219 @ $8.92 · Sale (S): 1,254 @ $8.71EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1898490 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →